Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Pulsatile Insulin Infusion Therapy on Vascular Function in Type 1 and Type 2 Diabetes Mellitus
2019-002758-21Phase 2Terminated
- Sponsor
- Innovative Diabetes Treatments
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of human insulin in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Innovative Diabetes Treatments. Primary endpoint: Endothelial function. Started Jul 2019; status: terminated.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2019-002758-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002758-21.